Search for Clinical Trial Results
Erythema - 209 Studies Found
Status | Study |
Completed |
Study Name: Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) Condition: Cutaneous Lupus Erythematosus (CLE) Date: 2008-03-04 Interventions: Drug: lenalidomide (Revlimid®) The drug will be administered in oral form. The dosage of lenalidomi |
Completed |
Study Name: Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion Condition: Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus Date: 2012-03-08 Interventions:
|
Recruiting |
Study Name: Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Condition:
|
Terminated |
Study Name: Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus Condition: Lupus Erythematosus, Cutaneous Date: 2011-08-01 Interventions: Drug: Alitretinoin 1 capsule Alitretinoin 30 mg per day; optional reduction to 10 mg per day in case una |
Recruiting |
Study Name: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Patients Condition: Lupus Erythematosus, Cutaneous Date: 2016-08-30 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus Condition: Lupus Erythematosus, Cutaneous Date: 2011-04-29 Interventions: Drug: Fumaric acid esters Starting from 1 tablet Fumaderm® initial per day, with titration up to 6 |
Completed |
Study Name: Cutaneous Lupus Erythematosus and Elidel Condition:
Interventions: Drug: Elidel (pimecrolimus) |
Enrolling by invitation |
Study Name: European Society of Cutaneous Lupus Erythematosus (EUSCLE) Condition:
|
Completed |
Study Name: A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus Condition:
|
Terminated |
Study Name: Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus Condition: Cutaneous Lupus Erythematosus Date: 2011-12-21 Interventions: Dietary Supplement: vitamin D The investigators will carry out a two-armed prospective pilot study of th |